SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-20-006405
Filing Date
2020-06-26
Accepted
2020-06-26 15:51:55
Documents
15

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 1806603
2 GRAPHIC g922470g02t12.jpg GRAPHIC 81210
3 GRAPHIC g922470g07t15.jpg GRAPHIC 89367
4 GRAPHIC g922470g14v50.jpg GRAPHIC 50578
5 GRAPHIC g922470g16k04.jpg GRAPHIC 82230
6 GRAPHIC g922470g19s60.jpg GRAPHIC 49788
7 GRAPHIC g922470g21c51.jpg GRAPHIC 58641
8 GRAPHIC g922470g23m05.jpg GRAPHIC 78515
9 GRAPHIC g922470g32b07.jpg GRAPHIC 50139
10 GRAPHIC g922470g34k00.jpg GRAPHIC 151261
11 GRAPHIC g922470g35o52.jpg GRAPHIC 112102
12 GRAPHIC g922470g38k77.jpg GRAPHIC 90348
13 GRAPHIC g922470g47b01.jpg GRAPHIC 109126
14 GRAPHIC g922470g56d20.jpg GRAPHIC 120443
15 GRAPHIC g922470g69q55.jpg GRAPHIC 39178
  Complete submission text file 0000950123-20-006405.txt   3398053
Mailing Address 8 CLARKE DRIVE CRANBURY NJ 08512
Business Address 8 CLARKE DRIVE CRANBURY NJ 08512 (609) 642-6664
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-03247 | Film No.: 20993917
SIC: 2834 Pharmaceutical Preparations